Which myelodysplastic syndromes patients are candidates for treatment with decitabine?

被引：1
|
作者：
Luebbert, M. [1 ]
机构：
[1] Univ Freiburg, Med Ctr, Div Hematol Oncol, D-7800 Freiburg, Germany
来源：
LEUKEMIA RESEARCH | 2007年 / 31卷
关键词：
D O I：
10.1016/S0145-2126(07)70036-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [1] Which myelodysplastic syndromes patients are candidates for treatment with azacitidine?
    Silverman, L. R.
    LEUKEMIA RESEARCH, 2007, 31 : S20 - S20
  • [2] Which myelodysplastic syndromes patients are candidates for transplantation?
    de Witte, T.
    van Biezen, A.
    Brand, R.
    Suciu, S.
    Kroeger, N.
    LEUKEMIA RESEARCH, 2007, 31 : S21 - S22
  • [3] Which myelodysplastic syndromes patients are candidates for treatment with hematopoietic growth factors?
    Fenaux, P.
    LEUKEMIA RESEARCH, 2007, 31 : S18 - S19
  • [4] Decitabine in the treatment of myelodysplastic syndromes
    Santos, Fabio P. S.
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Issa, Jean-Pierre
    Ravandi, Farhad
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (01) : 9 - 22
  • [5] Which myelodysplastic syndromes patients are candidates for agressive chemotherapy?
    Sanz, G. F.
    LEUKEMIA RESEARCH, 2007, 31 : S19 - S19
  • [6] The role of decitabine in the treatment of myelodysplastic syndromes
    Atallah, Ehab
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (01) : 65 - 73
  • [7] Decitabine treatment of patients with higher-risk myelodysplastic syndromes
    Steensma, David P.
    LEUKEMIA RESEARCH, 2009, 33 : S12 - S17
  • [8] PATIENTS' PERSPECTIVES ON ORAL DECITABINE AND CEDAZURIDINE FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES
    Zeidan, A.
    Perepezko, K.
    Salimi, T.
    Washington, T.
    Epstein, R.
    LEUKEMIA RESEARCH, 2023, 128
  • [9] Decitabine in myelodysplastic syndromes
    Saba, HI
    Wijermans, PW
    SEMINARS IN HEMATOLOGY, 2005, 42 (03) : S23 - S31
  • [10] Decitabine in myelodysplastic syndromes
    Saba, Hussain
    DRUGS, 2006, 66 (07) : 960 - 960
12345